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First in Human Transapical Implantation
of Transcatheter Inverted Aortic Valve
to Treat Native Mitral Valve Stenosis
Vaikom Subramanian Mahadevan, MD,* Imthiaz Manoly, MD,y Ragheb Hasan, MDyA fter our initial publication of the ﬁrst inhuman transapical implantation of an invertedtranscatheter (SAPIEN valve, Edwards Life-
sciences, Irvine, California) in the native mitral
position (1), we now report a 2-year clinical and echo-
cardiographic follow-up with transesophageal echo-
cardiographic images from the same patient. There
has been a further report of successful implantation
of transcatheter valve percutaneously as well for
native mitral valve stenosis (2).
As reported previously, an inverted 29-mm SAPIEN
valve was implanted in the native mitral position
2 years ago. The patient has been undergoing routine
clinical follow-up for 2 years and underwent further
transesophageal echocardiographic assessment at
20 months after providing informed consent to assess
valve function in detail because there are no follow-
up data on such implants in the native mitral
position.
During the follow-up-period, she was admitted to
the hospital for a respiratory infection and made a
good recovery. She had no cardiac issues, with good
exercise tolerance compared with her pre-procedural
status. Transesophageal echocardiography revealedFrom *Department of Cardiology, University of California, San Francisco, S
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tation (Figure 1, Online Videos 1 and 2). Mean gradient
across the mitral prosthesis was 7 mm Hg, which was
again very similar to the measurement post-
procedure (7 mm Hg). Prosthetic aortic valve func-
tion was well preserved (Figure 2, Online Videos 3
and 4). The patient had been continued on warfarin
during the entire follow-up, which she had been pre-
procedurally as well, because of her prosthetic aortic
valve.
We conclude that transcatheter valve therapy
using an inverted implantation of a SAPIEN XT pros-
thesis in the native mitral position has preserved
valve function with maintained clinical improvement
in this ﬁrst in-human implant patient. We therefore
recommend this as an alternate approach for patients
who are deemed unﬁt for surgery and hope that this
will pave the way for purposely designed trans-
catheter valves for native mitral disease in the future.
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FIGURE 1 Two-Dimensional Snapshots of the Transesophageal Echocardiogram Demonstrating the Closure and Color Doppler of the
Inverted Aortic Valve in the Mitral Position With Trivial Regurgitation
Two-dimensional snapshots of the transesophageal echocardiogram demonstrating the closure and color Doppler of the inverted aortic valve
with trivial regurgitation (Online Videos 1 and 2).
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FIGURE 2 Three-Dimensional Echocardiogram Images Showing Opening and Closing of the Inverted Transcatheter Aortic Valve
Replacement Valve Leaﬂets in the Mitral Position
Three-dimensional echocardiogram images showing opening and closing of the valve leaﬂets (Online Videos 3 and 4).
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APPENDIX For supplemental videos,
please see the online version of this article.
